IOL CHEMICALS & PHARM. | INNOVA CAPTAB LTD. | IOL CHEMICALS & PHARM./ INNOVA CAPTAB LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | - | - | View Chart |
P/BV | x | 1.6 | 9.7 | 16.1% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. INNOVA CAPTAB LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
INNOVA CAPTAB LTD. Mar-23 |
IOL CHEMICALS & PHARM./ INNOVA CAPTAB LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | NA | - | |
Low | Rs | 272 | NA | - | |
Sales per share (Unadj.) | Rs | 377.6 | 193.0 | 195.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 14.2 | 167.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 16.5 | 191.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 57.6 | 445.8% | |
Shares outstanding (eoy) | m | 58.71 | 48.00 | 122.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0 | - | |
Avg P/E ratio | x | 17.1 | 0 | - | |
P/CF ratio (eoy) | x | 12.8 | 0 | - | |
Price / Book Value ratio | x | 1.6 | 0 | - | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 548 | 307.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 9,264 | 239.3% | |
Other income | Rs m | 256 | 92 | 278.4% | |
Total revenues | Rs m | 22,427 | 9,356 | 239.7% | |
Gross profit | Rs m | 2,257 | 1,136 | 198.6% | |
Depreciation | Rs m | 462 | 111 | 416.7% | |
Interest | Rs m | 165 | 200 | 82.5% | |
Profit before tax | Rs m | 1,887 | 918 | 205.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 238 | 207.7% | |
Profit after tax | Rs m | 1,391 | 680 | 204.8% | |
Gross profit margin | % | 10.2 | 12.3 | 83.0% | |
Effective tax rate | % | 26.2 | 26.0 | 101.0% | |
Net profit margin | % | 6.3 | 7.3 | 85.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 4,425 | 218.5% | |
Current liabilities | Rs m | 5,025 | 2,776 | 181.1% | |
Net working cap to sales | % | 20.9 | 17.8 | 117.6% | |
Current ratio | x | 1.9 | 1.6 | 120.7% | |
Inventory Days | Days | 43 | 40 | 108.4% | |
Debtors Days | Days | 8 | 104 | 8.0% | |
Net fixed assets | Rs m | 11,017 | 3,058 | 360.3% | |
Share capital | Rs m | 587 | 480 | 122.3% | |
"Free" reserves | Rs m | 14,490 | 2,285 | 634.1% | |
Net worth | Rs m | 15,077 | 2,765 | 545.3% | |
Long term debt | Rs m | 0 | 1,342 | 0.0% | |
Total assets | Rs m | 20,684 | 7,482 | 276.4% | |
Interest coverage | x | 12.5 | 5.6 | 222.6% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.2 | 86.6% | |
Return on assets | % | 7.5 | 11.8 | 64.0% | |
Return on equity | % | 9.2 | 24.6 | 37.6% | |
Return on capital | % | 13.6 | 27.2 | 50.0% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 671 | 182.2% | |
From Investments | Rs m | -1,200 | -908 | 132.1% | |
From Financial Activity | Rs m | -41 | 271 | -15.2% | |
Net Cashflow | Rs m | -18 | 34 | -54.6% |
Indian Promoters | % | 48.2 | 50.9 | 94.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 22.7 | 7.5% | |
FIIs | % | 1.4 | 1.9 | 72.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.1 | 105.5% | |
Shareholders | 130,003 | 39,396 | 330.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | INNOVA CAPTAB LTD. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -1.66% | 0.45% |
1-Month | 5.76% | -0.12% | 2.55% |
1-Year | -2.63% | -14.23% | 56.14% |
3-Year CAGR | -12.88% | -4.99% | 15.22% |
5-Year CAGR | 16.82% | -3.02% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the INNOVA CAPTAB LTD. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of INNOVA CAPTAB LTD. the stake stands at 50.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of INNOVA CAPTAB LTD..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
INNOVA CAPTAB LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of INNOVA CAPTAB LTD..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.